2020-2027 Analysis and Review Serotonin Supplements Market

Serotonin Supplements Market

Serotonin Supplements Market By Clinical Application (Anxiety & Mood Disorders, Insomnia and Others), By Distribution Channel (Hypermarket, Retail Stores and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

09-06-2020 REP-HC-5111 40 Tables 120 pages Format

The serotonin supplements market was valued at USD 658.0 Mn by 2019. The rising prevalence of anxiety and mood disorders worldwide primarily drives market growth. Additionally, a constant rise in insomnia and altered sleep pattern across all age groups throughout the globe further accentuates the serotonin supplements market growth.

Serotonin Supplements Market

Serotonin supplements are a very safe and non-drug option for elevating the levels of neural serotonin which is a major neurotransmitter. The majority of prescription drugs used for treating mental disorders are exerting their pharmacological effect by increasing the serotonin levels, but the severe side effects associated with them renders them ineffective in the long term management of mental disorders. Serotonin supplements that boost the natural production of serotonin in the human body are 5-hydroxytryptophan, tryptophan, s-adenosyl methionine, pyridoxine, folic acid, L-theanine, Rhodiola Rosea, Garcinia cambogia, etc.

The major segments related to the serotonin supplements market are: 

By Clinical Application (2017–2027; US$ Mn)

Anxiety & Mood Disorders



By Distribution Channel (2017–2027; US$ Mn)


Retail Stores


Geography Segment (2017–2027; US$ Mn)

North America



United Kingdom
Rest of Europe

Asia Pacific

Rest of Asia Pacific

Latin America (LATAM)

Rest of Latin America

Middle East and Africa (MEA)

Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global serotonin supplements market
  • The overall segmentation of the serotonin supplements market, by clinical application, distribution channel, and geography is minutely studied. Anxiety & Mood disorders and hypermarkets are dominating the clinical application and distribution channel segments respectively
  • Rising prevalence of anxiety and mood disorders in young population worldwide
  • Significant increase in the number of the geriatric population suffering from insomnia

Report gist?

  • The study of the global serotonin supplements market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers a qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the nutraceutical industry actively engaged in the production and marketing of serotonin supplements due to the  rising prevalence of anxiety & mood disorders in young population worldwide
  • The report will benefit physicians prescribing medicines and supplements for treating insomnia in the elderly population throughout the globe
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to serotonin supplements market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Anxiety and mood disorders are representing the largest market share in the clinical application segment for the serotonin supplements market. According to the latest statistics provided by the World Bank data, the prevalence rate of anxiety is highly variegated ranging from 2.5% to 7% across various nations. Further clinical research studies suggest that approximately 1 in 133 individual suffers from anxiety during his lifetime. A mood disorder is seen to be growing at an unprecedented rate in the millennial population worldwide due to unhealthy diet, stress, poor social life, etc., which if unchecked may eventually result in depression and suicidal tendencies. Insomnia is keen to register comfortable market growth in the near future on account of the growing incidence of lack of sleep among the geriatric population worldwide and increasing consumption of caffeinated drinks across various age groups.

Hypermarkets are presently leading the distribution channel segment for the serotonin channel segments market. It provides a unique platform for several players to showcase their products under a single roof at attractive prices. Retail stores are the shopping option for consumers receiving prescription form dieticians and physicians for the management of chronic lifestyle disorders. E-commerce is expected to record excellent market growth during the forecast period owing to the deep internet penetration and capability to reach a large consumer base with good disposable income.

North America is currently dominating the geography segment for the serotonin supplements market. The rising prevalence of anxiety in the young population primarily drives the market growth in the region. According to the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 40 million United States citizens aged 18 years and above are reported to be suffering from anxiety. Stressful lifestyle, large consumption of tobacco, alcohol, and ecstasy substance has resulted in mood disorders leading to depression and suicidal tendencies increase the demand for serotonin supplements in the region. Europe is the second-largest regional segment owing to the rising prevalence of insomnia in the geriatric population. As per the latest information provided by the European Commission Report the minimum sleep hours duration for subjects suffering from insomnia is 5.77 hours, creating a huge demand for serotonin supplements in the region to provide sleep aid. The Asia Pacific is anticipated to be the fastest-growing regional segment for the serotonin supplements market. Flourishing traditional and herbal medicines enriched in 5HTP and tryptophan will steer the serotonin supplements market growth in the region.

Select License Type


Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.